ArticleJournal of neurosurgery. Case lessons2026
Spindle cell oncocytoma: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpindle cell oncocytoma (SCO) is a rare, nonadenomatous sellar tumor that often mimics pituitary adenomas both radiographically and clinically, making diagnosis and treatment difficult. OBSERVATIONS: A 67-year-old male presented with fatigue and weakness, with MRI revealing an enhancing sellar mass with suprasellar extension and laboratory findings consistent with panhypopituitarism. He underwent endoscopic endonasal resection, which revealed a fibrous, highly vascular tumor adherent to surrounding tissue, consistent with SCO on final pathological analysis. Gross-total resection (GTR) was achieved, and the patient has been monitored regularly with no signs of recurrence at 9 months postoperatively. LESSONS: SCOs are an exceedingly rare entity often indistinguishable from pituitary adenomas preoperatively, yet their intraoperative hypervascularity and fibrous texture can complicate resection and predispose patients to recurrence. Accurate identification of these tumors and GTR when possible are essential to appropriate treatment. https://thejns.org/doi/10.3171/CASE26333.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.